Cargando…
ZNF750 exerted its Antitumor Action in Oral Squamous Cell Carcinoma by regulating E2F2
Cell cycle activator E2F transcription factor 2 (E2F2) play a key role in tumor development and metastasis. Previous RNA sequence analysis (GSE134835) revealed E2F2 was significantly reduced by Zinc-finger protein 750 (ZNF750) in oral squamous cell carcinoma (OSCC). This study was aimed to determine...
Autores principales: | Yang, Hong-Li, Xu, Cong, Yang, Yi-Kun, Tang, Wen-Qiang, Hong, Min, Pan, Li, Chen, Hai-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734408/ https://www.ncbi.nlm.nih.gov/pubmed/35003347 http://dx.doi.org/10.7150/jca.63919 |
Ejemplares similares
-
ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma
por: Hazawa, M, et al.
Publicado: (2017) -
Pathway-focused PCR array profiling of CAL-27 cell with over-expressed ZNF750
por: Pan, Li, et al.
Publicado: (2017) -
m(6)A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression
por: Zhang, Panpan, et al.
Publicado: (2018) -
Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway
por: Xiao, Yue, et al.
Publicado: (2021) -
Association analysis identifies ZNF750 regulatory variants in psoriasis
por: Birnbaum, Ramon Y, et al.
Publicado: (2011)